GO:0046359 butyrate catabolic process: Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046359 (butyrate catabolic process) describes the biochemical breakdown of butyrate, the anion of butyric acid, a short-chain fatty acid produced by gut microbial fermentation.
• Butyrate is a major energy source for colonocytes and a potent inhibitor of histone deacetylases (HDACs), linking its catabolism to gene regulation and metabolic health.
• Key enzymes in butyrate catabolism include ACADS, ACADM, HADHA, HADHB, and ACAT1, which catalyze beta-oxidation steps in mitochondria.
• Butyrate catabolism influences insulin sensitivity, energy expenditure, and colonic homeostasis, with implications for diabetes, obesity, and inflammatory bowel disease.
• Microbiota-derived butyrate and its catabolic flux modulate immune responses and can potentiate CAR-T cell therapy by metabolic reprogramming.
• Research on butyrate catabolism uses CRISPR knockout, knock-in, overexpression models, metabolomics, and transcriptomics to dissect gene function and therapeutic potential.
Description
Butyrate catabolic process (GO:0046359) is the set of chemical reactions and pathways that result in the breakdown of butyrate, the anion of butyric acid. Butyrate is a short-chain fatty acid generated by microbial fermentation of dietary fiber in the colon, and it serves as a primary energy substrate for colonic epithelial cells. The catabolism of butyrate is therefore central to host-microbe metabolic exchange and intestinal health. Beyond energy production, butyrate catabolism influences cellular signaling, histone acetylation, and immune regulation, making it a focal point for researchers in metabolism, gastroenterology, and oncology. Understanding the genes and pathways that mediate butyrate breakdown is essential for developing therapeutic strategies that target metabolic and inflammatory diseases.
butyrate catabolic process At A Glance
| GO ID | GO:0046359 |
|---|---|
| GO term | butyrate catabolic process |
| Ontology | biological_process |
| Synonym | butanoic acid breakdown; butanoic acid catabolic process; butanoic acid catabolism; butanoic acid degradation; butyrate breakdown; butyrate catabolism; butyrate degradation |
| Major function | Breakdown of butyrate for energy production and metabolic signaling |
| Key enzymes | ACADS, ACADM, HADHA, HADHB, ACAT1 |
| Cellular location | Mitochondrial matrix |
| Related pathways | Beta-oxidation, short-chain fatty acid metabolism, histone deacetylase inhibition |
What Is GO:0046359?
According to the Gene Ontology, GO:0046359 butyrate catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of butyrate, the anion of butyric acid. This process encompasses the enzymatic steps that convert butyrate into smaller metabolites, primarily through beta-oxidation in mitochondria, and includes transport and activation steps required for its utilization.
Why Is butyrate catabolic process Important in Cell Biology?
Butyrate catabolic process is critically important because butyrate is a major energy source for colonocytes and a key mediator of host-microbe interactions. Its breakdown regulates energy homeostasis, insulin sensitivity, and inflammation, and dysregulation is linked to metabolic disorders, colorectal cancer, and neurodegenerative conditions. Moreover, butyrate catabolism influences epigenetic modifications through HDAC inhibition, affecting gene expression in health and disease.
• Provides energy for colonic epithelial cells, maintaining gut barrier integrity.
• Regulates insulin sensitivity and energy expenditure in metabolic tissues.
• Modulates immune responses and inflammation in the gut and systemically.
• Influences histone acetylation and gene expression via HDAC inhibition.
• Impacts gut-brain axis signaling and neuroprotection.
• Affects cancer cell metabolism and can enhance immunotherapy efficacy.
• Plays a role in early type 2 diabetes and retinal protection.
• Serves as a target for therapeutic interventions in metabolic and inflammatory diseases.
What Happens During butyrate catabolic process?
Uptake and Activation of Butyrate
In simple terms: Butyrate is taken up by cells and converted into a form that can be broken down for energy.
Butyrate enters cells via monocarboxylate transporters and is activated to butyryl-CoA by acyl-CoA synthetases. This activation step is required for subsequent beta-oxidation. In colonocytes, butyrate is rapidly metabolized, contributing to energy production and maintaining low intracellular concentrations to facilitate diffusion.
Beta-Oxidation Cycle
In simple terms: The activated butyrate is chopped into smaller pieces through a repeating cycle to release energy.
Butyryl-CoA undergoes beta-oxidation, a four-step cycle involving acyl-CoA dehydrogenase (ACADS), enoyl-CoA hydratase (HADHA/HADHB), 3-hydroxyacyl-CoA dehydrogenase, and thiolase (ACAT1). Each cycle shortens the fatty acid chain by two carbons, generating acetyl-CoA, FADH2, and NADH. These products feed into the TCA cycle and oxidative phosphorylation to produce ATP.
Energy Production and Metabolic Signaling
In simple terms: The breakdown products enter the energy-producing machinery and also send signals that affect cell behavior.
Acetyl-CoA from butyrate catabolism enters the TCA cycle, driving oxidative phosphorylation and ATP synthesis. This energy supply is crucial for colonocyte function and gut barrier maintenance. Additionally, butyrate catabolism influences cellular signaling pathways, including AMPK and mTOR, affecting insulin sensitivity and energy expenditure.
Regulation by Substrate Availability and Microbiota
In simple terms: The amount of butyrate available from gut bacteria controls how fast this process runs.
Butyrate production by gut microbiota is the primary determinant of substrate availability for catabolism. Dietary fiber intake modulates microbial fermentation and butyrate levels, which in turn affect catabolic flux in host tissues. This interplay is critical for colonic health and systemic metabolism.
Key Genes Involved in GO:0046359 butyrate catabolic process
The following genes encode enzymes and transporters directly involved in butyrate catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACADS | Short-chain acyl-CoA dehydrogenase; catalyzes first step of beta-oxidation | Target for studying butyrate oxidation defects |
| ACADM | Medium-chain acyl-CoA dehydrogenase; involved in fatty acid oxidation | Model for metabolic disorders affecting butyrate utilization |
| HADHA | Trifunctional enzyme subunit alpha; enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase | Key enzyme in beta-oxidation; mutations cause fatty acid oxidation disorders |
| HADHB | Trifunctional enzyme subunit beta; thiolase activity | Essential for butyrate catabolism; studied in mitochondrial diseases |
| ACAT1 | Acetyl-CoA acetyltransferase; thiolase in beta-oxidation | Involved in ketone body metabolism and butyrate breakdown |
| SLC16A1 | Monocarboxylate transporter 1; mediates butyrate uptake | Regulates intracellular butyrate levels for catabolism |
| SLC16A3 | Monocarboxylate transporter 4; butyrate transport | Potential target for modulating butyrate availability |
| ACSM3 | Acyl-CoA synthetase medium-chain family member 3; activates butyrate | Required for butyryl-CoA formation |
| ACSM1 | Acyl-CoA synthetase medium-chain family member 1; butyrate activation | Involved in short-chain fatty acid metabolism |
| CPT1A | Carnitine palmitoyltransferase 1A; mitochondrial import of fatty acids | Regulates entry of butyrate derivatives into mitochondria |
| CPT2 | Carnitine palmitoyltransferase 2; inner mitochondrial membrane transport | Mutations affect beta-oxidation of butyrate |
| ETFA | Electron transfer flavoprotein subunit alpha; accepts electrons from ACADS | Links beta-oxidation to respiratory chain |
| ETFB | Electron transfer flavoprotein subunit beta | Component of electron transfer pathway for butyrate oxidation |
| ETFDH | Electron transfer flavoprotein dehydrogenase | Final electron acceptor in beta-oxidation |
| PPARA | Peroxisome proliferator-activated receptor alpha; regulates fatty acid oxidation genes | Transcriptional regulator of butyrate catabolism |
| PPARD | Peroxisome proliferator-activated receptor delta; modulates lipid metabolism | Influences butyrate oxidation capacity |
| SIRT1 | NAD-dependent deacetylase; regulates metabolic genes | Links butyrate metabolism to epigenetic regulation |
| HDAC1 | Histone deacetylase 1; inhibited by butyrate | Mediates epigenetic effects of butyrate |
How Is butyrate catabolic process Regulated?
Butyrate catabolic process is regulated at multiple levels. Substrate availability from gut microbial fermentation is a primary determinant, influenced by dietary fiber intake. Transcriptional regulation by PPAR alpha and other nuclear receptors controls the expression of beta-oxidation enzymes. Additionally, butyrate itself inhibits histone deacetylases (HDACs), leading to changes in gene expression that can feedback on metabolic pathways. Hormonal signals such as insulin and glucagon also modulate butyrate oxidation in metabolic tissues.
butyrate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACADS | Short-chain acyl-CoA dehydrogenase deficiency | ACADS knockout cell line; metabolomics |
| HADHA | Mitochondrial trifunctional protein deficiency | HADHA knockout iPSC-derived hepatocytes |
| PPARA | Metabolic syndrome, fatty liver | PPARA knockout mouse; butyrate oxidation assay |
| HDAC1 | Colorectal cancer, neuroinflammation | HDAC1 overexpression in colon cancer cells |
| SLC16A1 | Diabetes, cancer metabolism | SLC16A1 knockout cells; butyrate uptake assay |
Metabolic Disorders: Diabetes and Obesity
Butyrate catabolism is linked to improved insulin sensitivity and increased energy expenditure. In mice, butyrate supplementation improves insulin sensitivity and enhances energy metabolism, suggesting that catabolic flux influences systemic glucose homeostasis. In early type 2 diabetes, butyrate exerts systemic and retinal protective effects via gut microbiota-lipid metabolism interactions. Dysregulation of butyrate catabolism may contribute to metabolic syndrome.
Colorectal Cancer and Gut Health
Butyrate is the preferred energy source for colonocytes, and its catabolism is essential for maintaining colonic homeostasis. In colorectal cancer, butyrate can exert anti-proliferative effects, partly through HDAC inhibition and metabolic reprogramming. The balance between butyrate oxidation and its epigenetic effects influences tumor cell behavior.
Neurodegeneration and Gut-Brain Axis
Butyrate catabolism impacts the gut-brain axis, with butyrate acting as a neuroprotective agent. The neuropharmacology of butyrate includes modulation of histone acetylation and neuroinflammation, relevant to neurodegenerative diseases. Microbial butyrate production and host catabolism influence brain function and behavior.
Cancer Immunotherapy
Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling, highlighting the role of butyrate catabolism in immune cell function. This suggests that modulating butyrate levels could enhance immunotherapy efficacy.
From butyrate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ACADS loss impair butyrate oxidation? | ACADS knockout cell line (CRISPR) |
| Does a point mutation in HADHA affect enzyme activity? | HADHA point-mutation knock-in cells |
| Can butyrate catabolism be enhanced by PPARA overexpression? | PPARA overexpression cell model |
| Does SLC16A1 mediate butyrate uptake? | SLC16A1 knockout and tagged knock-in cells |
| How does butyrate affect histone acetylation? | HDAC1 knockout and overexpression models |
| Does butyrate potentiate CAR-T therapy? | MSLN CAR-T cells treated with butyrate; metabolic assays |
How to Study the butyrate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Butyrate and intermediate levels | Quantify catabolic flux in cells |
| 13C-butyrate tracing | Flux through beta-oxidation and TCA cycle | Metabolic reprogramming studies |
| RNA-seq | Gene expression changes | Identify regulatory networks |
| Enzyme activity assay | Catalytic activity of ACADS, HADHA | Validate mutations |
| CRISPR knockout screen | Genes required for butyrate catabolism | Discover novel regulators |
| ChIP-seq | Histone acetylation marks | Epigenetic effects of butyrate |
| Seahorse respirometry | Oxygen consumption rate | Measure oxidative phosphorylation |
| Western blot | Protein expression of beta-oxidation enzymes | Validate knockout/overexpression |
Metabolomics and Flux Analysis
Metabolomics using mass spectrometry can quantify butyrate and its catabolic intermediates (butyryl-CoA, acetyl-CoA) in cells and tissues. Stable isotope tracing with 13C-butyrate allows flux analysis through beta-oxidation and TCA cycle, revealing metabolic reprogramming.
Transcriptomics and RNA-seq
RNA sequencing can identify genes differentially expressed upon modulation of butyrate catabolism, including beta-oxidation enzymes and HDAC targets. This approach helps define regulatory networks and biomarkers.
Enzyme Activity Assays
In vitro enzyme assays using recombinant ACADS, HADHA, or ACAT1 measure catalytic activity and kinetics. These assays are used to validate the impact of point mutations or knockouts on butyrate breakdown.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes essential for butyrate catabolism and its downstream effects, such as cell survival under butyrate treatment. This unbiased approach reveals novel regulators and therapeutic targets.
How CRISPR Can Be Used to Study GO:0046359 butyrate catabolic process
Knockout
CRISPR knockout of genes such as ACADS, HADHA, or SLC16A1 can abolish butyrate catabolism, leading to accumulation of butyrate and altered cellular metabolism. These models are used to study the consequences of impaired butyrate oxidation in colonocytes and other cell types.
Point Mutation
Introducing point mutations in genes like HADHA or ACADM via CRISPR base editing or homology-directed repair allows researchers to model enzyme deficiencies and assess their impact on butyrate catabolic flux and cellular phenotypes.
Knock-in
Knock-in of tagged versions of butyrate catabolism enzymes (e.g., HADHA-FLAG) enables affinity purification and interaction studies. Knock-in of reporter genes can track enzyme expression and localization in real time.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PPARA or ACADS can enhance butyrate catabolism, providing models to study increased flux and its effects on energy homeostasis and gene expression.
How EDITGENE Supports butyrate catabolic process Research
Researchers studying butyrate catabolic process-related genes often need to determine whether a candidate gene is causally involved in butyrate breakdown, metabolic signaling, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for butyrate catabolic process research.
Frequently Asked Questions About butyrate catabolic process
What is butyrate catabolic process?
Butyrate catabolic process (GO:0046359) is the biochemical breakdown of butyrate, a short-chain fatty acid, primarily through beta-oxidation to produce energy.
What genes are involved in butyrate catabolic process?
Key genes include ACADS, ACADM, HADHA, HADHB, ACAT1, SLC16A1, and PPARA, which encode enzymes and transporters for butyrate uptake and oxidation.
Why is butyrate catabolism important for colon health?
Butyrate is the main energy source for colonocytes; its catabolism maintains gut barrier integrity and reduces inflammation.
How does butyrate catabolism affect insulin sensitivity?
Butyrate improves insulin sensitivity and increases energy expenditure in mice, partly through its catabolic flux and signaling.
What diseases are linked to butyrate catabolic process?
Diseases include diabetes, obesity, colorectal cancer, neurodegenerative disorders, and metabolic syndrome.
How can I study butyrate catabolism in the lab?
Use metabolomics, 13C-butyrate tracing, enzyme assays, and CRISPR knockout models to measure flux and gene function.
What is the role of HDAC inhibition in butyrate catabolism?
Butyrate inhibits HDACs, linking its catabolism to epigenetic regulation and gene expression changes.
Can butyrate catabolism be targeted for cancer therapy?
Yes, butyrate potentiates CAR-T cell therapy and affects cancer cell metabolism, making it a therapeutic target.
What CRISPR models are available for butyrate catabolism research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like ACADS, HADHA, and PPARA.
Where can I find services for butyrate catabolism CRISPR models?
EDITGENE provides custom CRISPR services including knockout, knock-in, overexpression, and library screening for butyrate catabolism genes.
Conclusion
Butyrate catabolic process (GO:0046359) is a fundamental metabolic pathway with far-reaching implications for gut health, energy homeostasis, and disease. The enzymes and transporters involved, such as ACADS, HADHA, and SLC16A1, are critical for butyrate oxidation and its downstream effects on gene expression and immune function. Continued research using CRISPR models and advanced omics will uncover new therapeutic opportunities targeting butyrate catabolism in metabolic, inflammatory, and neoplastic diseases.
References
- 1. Liu H et al.. 2018. Butyrate: A Double-Edged Sword for Health?. Adv Nutr 9(1):21-29 PMID: 29438462
- 2. Stilling RM et al.. 2016. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?. Neurochem Int 99:110-132 PMID: 27346602
- 3. Gao Z et al.. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice.. Diabetes 58(7):1509-17 PMID: 19366864
- 4. Cummings JH et al.. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood.. Gut 28(10):1221-7 PMID: 3678950
- 5. Hamer HM et al.. 2008. Review article: the role of butyrate on colonic function.. Aliment Pharmacol Ther 27(2):104-19 PMID: 17973645
- 6. Chen J et al.. 2025. Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.. Biomed Pharmacother 192:118560 PMID: 40967080
- 7. Bach Knudsen KE et al.. 2003. New insight into butyrate metabolism.. Proc Nutr Soc 62(1):81-6 PMID: 12740062
- 8. Gong H et al.. 2025. Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota-Lipid Metabolism Interaction.. Nutrients 17(14) PMID: 40732988
